Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR – Free Report) – Research analysts at HC Wainwright issued their Q3 2026 earnings estimates for Pharming Group in a research report issued to clients and investors on Thursday, March 12th. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings per share of $0.12 for the […]

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities research analysts at HC Wainwright increased their Q1 2026 earnings estimates for Amylyx Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 4th. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.34) per share for the quarter, up […]